# ASSURE WCD Clinical Evaluation - Detection and Safety Study

Study · id `cardio:ct-nct03887052` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03887052](<https://clinicaltrials.gov/study/NCT03887052>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03887052

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

## Technical summary

Registry record NCT03887052. Allocation not applicable; no masking; primary purpose other. Start 2019-03-20 (actual); primary completion 2019-06-18 (actual). Results posted on 2023-10-26.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT03887052, source copy `cardio:ctgov-nct03887052-2024-03-12`, retrieved 2026-10-26)
- Started: 2019-03-20 (actual) (ClinicalTrials.gov record NCT03887052, source copy `cardio:ctgov-nct03887052-2024-03-12`, retrieved 2026-10-26)
- Primary completion: 2019-06-18 (actual) (ClinicalTrials.gov record NCT03887052, source copy `cardio:ctgov-nct03887052-2024-03-12`, retrieved 2026-10-26)
- Completion: 2019-06-18 (actual) (ClinicalTrials.gov record NCT03887052, source copy `cardio:ctgov-nct03887052-2024-03-12`, retrieved 2026-10-26)
- Results first posted: 2023-10-26 (ClinicalTrials.gov record NCT03887052, source copy `cardio:ctgov-nct03887052-2024-03-12`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03887052, source copy `cardio:ctgov-nct03887052-2024-03-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03887052-2024-03-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: ASSURE WCD Clinical Evaluation - Detection and Safety Study
- Acronym: ACE-DETECT
- Condition: Cardiac Arrest, Sudden
- Intervention (Device): ASSURE™ Wearable Cardioverter Defibrillator (WCD)
- Lead sponsor: Kestra Medical Technologies, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Regulatory and Clinical Research Institute Inc
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)

## Provenance

Content hash: ae5d0bddbcb63741b053a0324d6a2f990c88d37dcb3ca70e633eb76da4056fd7
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
